UBS Group’s Cognex CGNX Stock Holding History

UBS Group’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48,300	Closed	-$2.19M	–	10565
2025 Q3	$2.19M	Buy	+48,300	New	+$1.95M	﹤0.01%	4860

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group's CGNX Position: Q1 2026 in Review

UBS Group reduced its Cognex (CGNX) stake by 36% in Q1 2026, selling an estimated $13.8M and leaving 526,396 shares worth $25.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

UBS Group first reported a position in CGNX in Q4 2014 and has held it in 46 quarters since. The position peaked at $54.5M in Q3 2025. 570 funds tracked by Wall St. Rank hold CGNX as of Q1 2026.

UBS Group held 526,396 shares of Cognex worth $25.8M as of Q1 2026.
UBS Group sold 294,754 Cognex shares in Q1 2026, an estimated $13.8M.
Cognex made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2317 holding.
UBS Group first reported a position in Cognex in Q4 2014 and has held it in 46 quarters since.
UBS Group's Cognex position peaked at $54.5M in Q3 2025.
570 funds tracked by Wall St. Rank held Cognex as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.